Nubratori, Inc 2025-05-07 Health serious FDA
Health · FDA · Recall #FDA-D-0392-2025
Dexonto 0.4% (dexamethasone sodium phosphate) solution 20 mg/5 mL (4 mg/mL), Rx Only, 12… Recall
Issued May 7, 2025 · Nubratori, Inc
In May 2025, Nubratori, Inc recalled the Dexonto 0.4% (dexamethasone sodium phosphate) solution 20 mg/5 mL (4 mg/mL), Rx Only, 12…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Labeling: Incorrect or Missing Lot and/or Expiration date: Individual vials of Dexonto 0.4%, are labeled correctly with the BUD of 12/25/2024, however, the outer box on some of the Dexonto 0.4% are labeled incorrectly with a BUD of 12/25/2025.
What you should do
- 1 Stop using Dexonto 0.4% (dexamethasone sodium phosphate) solution 20 mg/5 mL (4 mg/mL), Rx Only, 12… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Nubratori, Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Nubratori, Inc
- Category
- Health
- Recall date
- May 7, 2025
- Units affected
- Not reported
- Sold at
- PA and CA.
- Recall number
- FDA-D-0392-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- Nubratori, Inc has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.